Skip to main content
Clinical Trials/CTRI/2021/03/032392
CTRI/2021/03/032392
Not yet recruiting
Phase 4

The Safety and Efficacy of Intralesional Steroid versus Intralesional Verapamil in patients with keloid and hypertrophic scars

MGM Medical College and Hospital Aurangabad0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: L910- Hypertrophic scar
Sponsor
MGM Medical College and Hospital Aurangabad
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
MGM Medical College and Hospital Aurangabad

Eligibility Criteria

Inclusion Criteria

  • 1\.Keloid lesions present on trunk, upper limb, back.
  • 2\.Patients willing to undergo treatment and come for follow up.

Exclusion Criteria

  • 1\.Patient with immunocompromised disorders.2\.Pregnant women \& women who intend to become pregnant.
  • 3\.Patients with secondary infection at the site of lesion.
  • 4\.Patients who are already on systemic steroids.
  • 5\.Patients who are already on systemic verapamil

Outcomes

Primary Outcomes

Not specified

Similar Trials